Diindolylmethane in Treating Patients Undergoing Surgery for Stage I or Stage II Prostate Cancer
Completed · Phase 1 · Has a placebo group
Conditions studied: Adenocarcinoma of the Prostate, Prostate Cancer, Stage I Prostate Cancer, Stage II Prostate Cancer
In brief
Giving diindolylmethane, a substance found in cruciferous vegetables, may help doctors learn more about how diindolylmethane is used by the body. This randomized phase I trial is studying the side effects and best dose of diindolylmethane compared with a placebo in treating patients undergoing radical prostatectomy for stage I or stage II prostate cancer.
Key facts
- Study ID
- NCT00450229
- Run by
- National Cancer Institute (NCI)
- People needed
- 45
- Starts
- 2007-02-01
- Expected to finish
- 2010-02-01
- Last updated by the study team
- 2015-12-04
Who can join
Age: 18 and older. Sex: male. Healthy volunteers: not accepted.
Where it is running
- University of Wisconsin Hospital and Clinics — Madison, Wisconsin, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.